Secretion of Active Membrane Type 1 Matrix Metalloproteinase (MMP-14) Into Extracellular Space in Microvesicular Exosomes

被引:221
作者
Hakulinen, Juha [1 ]
Sankkila, Lotta
Sugiyama, Nami
Lehti, Kaisa
Keski-Oja, Jorma
机构
[1] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland
关键词
MATRIX METALLOPROTEINASE; MT1-MMP; EXOSOME; CD9; TSG101; B1-INTEGRIN; CD29; CANCER; VESICLE;
D O I
10.1002/jcb.21923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Membrane type 1 matrix metalloproteinase (MT1-MMP, MMP14) is an efficient extracellular matrix (ECM) degrading enzyme that plays important roles in tissue homeostasis and cell invasion. Like a number of type I membrane proteins, MT1-MMP can be internalized from the cell surface through early and recycling endosomes to late endosomes, and recycled to the plasma membrane. Late endosomes participate in the biogenesis of small (30-100 nm) vesicles, exosomes, which redirect plasma membrane proteins for extracellular secretion. We hypothesized that some of the endosomal MT1-MMP could be directed to exosomes for extracellular release. Using cultured human fibrosarcoma (HT-1080) and melanoma (G361) cells we provide evidence that both the full-length 60 kDa and the proteolytically processed 43 kDa forms of MT1-MMP are secreted in exosomes. The isolated exosomes were identified by their vesicular structure in electron microscopy and by exosomal marker proteins CD9 and tumor susceptibility gene (TSG101). Furthermore, exosomes contained beta 1-integrin (CD29). The exosomes were able to activate pro-MMP-2 and degrade type 1 collagen and gelatin, suggesting that the exosomal MT1-MMP was functionally active. The targeting of MT1-MMP in exosomes represents a novel mechanism for cancer cells to secrete membrane type metalloproteolytic activity into the extracellular space. J. Cell. Biochem. 105: 1211-1218, 2008. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:1211 / 1218
页数:8
相关论文
共 44 条
  • [1] Malignant effusions and immunogenic tumour-derived exosomes
    Andre, F
    Schartz, NEC
    Movassagh, M
    Flament, C
    Pautier, P
    Morice, P
    Pomel, C
    Lhomme, C
    Escudier, B
    Le Chevalier, T
    Tursz, T
    Amigorena, S
    Raposo, G
    Angevin, E
    Zitvogel, L
    [J]. LANCET, 2002, 360 (9329) : 295 - 305
  • [2] Tumor-derived exosomes:: a new source of tumor rejection antigens
    André, F
    Scharz, NEC
    Chaput, N
    Flament, C
    Raposo, G
    Amigorena, S
    Angevin, E
    Zitvogel, L
    [J]. VACCINE, 2002, 20 : A28 - A31
  • [3] MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway
    Bravo-Cordero, Jose J.
    Marrero-Diaz, Raquel
    Megias, Diego
    Genis, Laura
    Garcia-Grande, Aranzazu
    Garcia, Maria A.
    Arroyo, Alicia G.
    Montoya, Maria C.
    [J]. EMBO JOURNAL, 2007, 26 (06) : 1499 - 1510
  • [4] Adhesion and signaling by B cell-derived exosomes: the role of integrins
    Clayton, A
    Turkes, A
    Dewitt, S
    Steadman, R
    Mason, MD
    Hallett, MB
    [J]. FASEB JOURNAL, 2004, 18 (06) : 977 - +
  • [5] Human tumor-derived exosomes selectively impair lymphocyte responses to interieukin-2
    Clayton, Aled
    Mitchell, J. Paul
    Court, Jacquelyn
    Mason, Malcolm D.
    Tabi, Zsuzsanna
    [J]. CANCER RESEARCH, 2007, 67 (15) : 7458 - 7466
  • [6] Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface
    Denzer, K
    van Eijk, M
    Kleijmeer, MJ
    Jakobson, E
    de Groot, C
    Geuze, HJ
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (03) : 1259 - 1265
  • [7] Denzer K, 2000, J CELL SCI, V113, P3365
  • [8] ECM regulates MT1-MMP localization with β1 or αvβ3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells
    Gálvez, BG
    Matías-Román, S
    Yáñez-Mó, M
    Sánchez-Madrid, F
    Arroyo, AG
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 159 (03) : 509 - 521
  • [9] Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling
    Gálvez, BG
    Matías-Román, S
    Albar, JP
    Sánchez-Madrid, F
    Arroyo, AG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) : 37491 - 37500
  • [10] Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model
    Gelderman, KA
    Hakulinen, J
    Hagenaars, M
    Kuppen, PJK
    Meri, S
    Gorter, A
    [J]. MOLECULAR IMMUNOLOGY, 2003, 40 (01) : 13 - 23